Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Biogen Gross Profit 2006-2019 | BIIB

Biogen annual/quarterly gross profit history and growth rate from 2006 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Biogen gross profit for the quarter ending June 30, 2019 was $3.140B, a 6.98% increase year-over-year.
  • Biogen gross profit for the twelve months ending June 30, 2019 was $12.044B, a 8.25% increase year-over-year.
  • Biogen annual gross profit for 2018 was $11.637B, a 9.33% increase from 2017.
  • Biogen annual gross profit for 2017 was $10.644B, a 6.76% increase from 2016.
  • Biogen annual gross profit for 2016 was $9.97B, a 4.69% increase from 2015.
  
Biogen Annual Gross Profit
(Millions of US $)
2018 $11,637
2017 $10,644
2016 $9,970
2015 $9,523
2014 $8,532
2013 $6,075
2012 $4,971
2011 $4,582
2010 $4,316
2009 $3,995
2008 $3,696
2007 $2,836
2006 $2,409
2005 $2,049
Biogen Quarterly Gross Profit
(Millions of US $)
Q2 2019 $3,140
Q1 2019 $2,888
Q4 2018 $3,038
Q3 2018 $2,978
Q2 2018 $2,936
Q1 2018 $2,685
Q4 2017 $2,798
Q3 2017 $2,708
Q2 2017 $2,712
Q1 2017 $2,426
Q4 2016 $2,494
Q3 2016 $2,539
Q2 2016 $2,524
Q1 2016 $2,414
Q4 2015 $2,507
Q3 2015 $2,468
Q2 2015 $2,306
Q1 2015 $2,243
Q4 2014 $2,343
Q3 2014 $2,209
Q2 2014 $2,130
Q1 2014 $1,851
Q4 2013 $1,707
Q3 2013 $1,593
Q2 2013 $1,493
Q1 2013 $1,281
Q4 2012 $1,284
Q3 2012 $1,246
Q2 2012 $1,282
Q1 2012 $1,159
Q4 2011 $1,187
Q3 2011 $1,186
Q2 2011 $1,108
Q1 2011 $1,100
Q4 2010 $1,119
Q3 2010 $1,080
Q2 2010 $1,106
Q1 2010 $1,012
Q4 2009 $1,027
Q3 2009 $1,027
Q2 2009 $1,003
Q1 2009 $938
Q4 2008 $968
Q3 2008 $985
Q2 2008 $901
Q1 2008 $841
Q4 2007 $806
Q3 2007 $708
Q2 2007 $689
Q1 2007 $634
Q4 2006 $646
Q3 2006 $637
Q2 2006 $582
Q1 2006 $544
Q4 2005 $520
Q3 2005 $507
Q2 2005 $535
Q1 2005 $488
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $41.611B $13.453B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.075B 13.90
Gilead Sciences (GILD) United States $82.611B 10.15
CSL (CSLLY) Australia $77.981B 0.00
Celgene (CELG) United States $72.150B 11.16
Vertex Pharmaceuticals (VRTX) United States $45.680B 49.37
Illumina (ILMN) United States $45.651B 53.64
Regeneron Pharmaceuticals (REGN) United States $33.122B 15.03
Alexion Pharmaceuticals (ALXN) United States $22.420B 11.82
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.379B 0.00
Incyte (INCY) United States $16.653B 49.01
Seattle Genetics (SGEN) United States $13.898B 0.00
Genmab (GNMSF) Denmark $12.636B 70.88
Exact Sciences (EXAS) United States $12.611B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.186B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.175B 54.54
Alnylam Pharmaceuticals (ALNY) United States $9.106B 0.00
Galapagos (GLPG) Belgium $8.936B 0.00
Bio-Techne Corp (TECH) United States $7.635B 52.75
Sarepta Therapeutics (SRPT) United States $6.500B 0.00
QIAGEN (QGEN) Netherlands $6.355B 20.87
BeiGene (BGNE) Cayman Islands $6.328B 0.00
Guardant Health (GH) United States $6.299B 0.00
Amarin (AMRN) Ireland $5.855B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.777B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.310B 13.50
Reata Pharmaceuticals (RETA) United States $5.214B 0.00
Exelixis (EXEL) United States $5.149B 13.39
Bluebird Bio (BLUE) United States $5.048B 0.00
Moderna (MRNA) United States $4.801B 0.00
China Biologic Products (CBPO) China $4.553B 28.42
ARGENX SE-ADR (ARGX) Netherlands $4.494B 0.00
Medicines (MDCO) United States $4.443B 0.00
Ascendis Pharma (ASND) Denmark $4.217B 0.00
Repligen (RGEN) United States $4.084B 79.26
Spark Therapeutics (ONCE) United States $3.887B 0.00
Blueprint Medicines (BPMC) United States $3.673B 0.00
MorphoSys AG (MOR) Germany $3.482B 0.00
Mirati Therapeutics (MRTX) United States $3.422B 0.00
Immunomedics (IMMU) United States $3.045B 0.00
Emergent Biosolutions (EBS) United States $2.795B 41.99
Alkermes (ALKS) Ireland $2.786B 0.00
Genmab (GMAB) Denmark $2.701B 0.00
Genomic Health (GHDX) United States $2.632B 49.36
MyoKardia (MYOK) United States $2.625B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.532B 0.00
Arena Pharmaceuticals (ARNA) United States $2.437B 5.24
Halozyme Therapeutics (HALO) United States $2.312B 0.00
Acceleron Pharma (XLRN) United States $2.279B 0.00
Myriad Genetics (MYGN) United States $2.263B 23.58
RA PHARMCTL INC (RARX) United States $2.198B 0.00
NeoGenomics (NEO) United States $2.122B 113.50
Intercept Pharmaceuticals (ICPT) United States $2.106B 0.00
Amicus Therapeutics (FOLD) United States $2.083B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.072B 0.00
Ligand Pharmaceuticals (LGND) United States $2.057B 26.00
Cambrex (CBM) United States $2.002B 25.32
Zai Lab (ZLAB) China $1.983B 0.00
Akcea Therapeutics (AKCA) United States $1.761B 0.00
UniQure (QURE) Netherlands $1.674B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.585B 0.00
Insmed (INSM) United States $1.564B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.504B 0.00
Denali Therapeutics (DNLI) United States $1.451B 0.00
REGENXBIO (RGNX) United States $1.437B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.397B 0.00
Coherus BioSciences (CHRS) United States $1.339B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.210B 0.00
Zymeworks (ZYME) Canada $1.176B 0.00
Innoviva (INVA) United States $1.107B 3.20
Dicerna Pharmaceuticals (DRNA) United States $1.080B 0.00
Alector (ALEC) United States $1.036B 0.00
AnaptysBio (ANAB) United States $1.009B 0.00
Editas Medicine (EDIT) United States $1.008B 0.00
Sangamo Therapeutics (SGMO) United States $0.998B 0.00
Fate Therapeutics (FATE) United States $0.960B 0.00
Epizyme (EPZM) United States $0.953B 0.00
ANI Pharmaceuticals (ANIP) United States $0.888B 14.83
Achillion Pharmaceuticals (ACHN) United States $0.866B 0.00
Zealand Pharma (ZEAL) Denmark $0.865B 9.71
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Athenex (ATNX) United States $0.835B 0.00
Codexis (CDXS) United States $0.808B 0.00
Twist Bioscience (TWST) United States $0.806B 0.00
Anika Therapeutics (ANIK) United States $0.803B 28.43
Cara Therapeutics (CARA) United States $0.788B 0.00
Principia Biopharma (PRNB) United States $0.761B 394.00
Vanda Pharmaceuticals (VNDA) United States $0.729B 26.31
Pharming Group (PHGUF) Netherlands $0.724B 0.00
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
WAVE Life Sciences (WVE) Singapore $0.721B 0.00
Vericel (VCEL) United States $0.684B 0.00
Revance Therapeutics (RVNC) United States $0.676B 0.00
Cytokineticsorporated (CYTK) United States $0.665B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.644B 0.00
Mesoblast (MESO) Australia $0.619B 0.00
Heska (HSKA) United States $0.596B 77.27
GENFIT S.A (GNFT) France $0.560B 0.00
MiMedx (MDXG) United States $0.556B 0.00
Intellia Therapeutics (NTLA) United States $0.555B 0.00
Arvinas (ARVN) United States $0.524B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.519B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
PHARMA MAR SA (PHMMF) Spain $0.494B 0.00
Retrophin (RTRX) United States $0.491B 0.00
DBV Technologies S.A (DBVT) France $0.474B 0.00
Intra-Cellular Therapies (ITCI) United States $0.469B 0.00
UROGEN PHARMA (URGN) United States $0.468B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.462B 0.00
BioDelivery Sciences (BDSI) United States $0.461B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Adverum Biotechnologies (ADVM) United States $0.454B 0.00
Cellectis S.A (CLLS) France $0.448B 0.00
Stemline Therapeutics (STML) United States $0.396B 0.00
Bellus Health (BLU) Canada $0.393B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.387B 0.00
Arcus Biosciences (RCUS) United States $0.386B 0.00
Merus (MRUS) Netherlands $0.376B 0.00
Agenus (AGEN) United States $0.368B 0.00
Kadmon Holdings (KDMN) United States $0.364B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.346B 0.00
Precision BioSciences (DTIL) United States $0.345B 0.00
AC Immune SA (ACIU) Switzerland $0.334B 24.75
CytomX Therapeutics (CTMX) United States $0.323B 0.00
Prothena (PRTA) Ireland $0.320B 0.00
Protagonist Therapeutics (PTGX) United States $0.317B 0.00
Avid Bioservices (CDMO) United States $0.299B 0.00
Gritstone Oncology (GRTS) United States $0.298B 0.00
Syros Pharmaceuticals (SYRS) United States $0.295B 0.00
Kindred Biosciences (KIN) United States $0.292B 0.00
Cellular Biomedicine (CBMG) United States $0.287B 0.00
Geron (GERN) United States $0.281B 0.00
Scholar Rock Holding (SRRK) United States $0.280B 0.00
Starpharma Holdings (SPHRY) Australia $0.279B 0.00
PDL BioPharma (PDLI) United States $0.278B 7.15
Dynavax Technologies (DVAX) United States $0.276B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.271B 0.00
Biofrontera AG (BFRA) Germany $0.265B 395.33
Theratechnologies (THTX) Canada $0.263B 0.00
ADMA Biologics Inc (ADMA) United States $0.262B 0.00
Puma Biotechnology (PBYI) United States $0.260B 0.00
Seres Therapeutics (MCRB) United States $0.243B 0.00
MannKind (MNKD) United States $0.243B 0.00
Inovio Pharmaceuticals (INO) United States $0.234B 0.00
OSMOTICA PHARM (OSMT) United States $0.232B 0.00
Sutro Biopharma (STRO) United States $0.230B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.230B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Albireo Pharma (ALBO) United States $0.227B 0.00
Sorrento Therapeutics (SRNE) United States $0.219B 0.00
Kamada (KMDA) Israel $0.213B 8.14
Spero Therapeutics (SPRO) United States $0.212B 0.00
Athersys (ATHX) United States $0.211B 0.00
Exicure (XCUR) United States $0.205B 0.00
Compugen (CGEN) Israel $0.205B 0.00
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Clovis Oncology (CLVS) United States $0.200B 0.00
ChromaDex (CDXC) United States $0.198B 0.00
Affimed (AFMD) Germany $0.191B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.189B 0.00
Prometic Life Sciences (PFSCF) Canada $0.177B 0.00
Dyadic (DYAI) United States $0.177B 0.00
Nicox SA (NICXF) France $0.175B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.170B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Senesco Technologies (ELOX) United States $0.164B 0.00
Cue Biopharma (CUE) United States $0.163B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
XOMA (XOMA) United States $0.161B 0.00
Enzo Biochem (ENZ) United States $0.154B 0.00
Cerecor (CERC) United States $0.153B 0.00
Arsanis (XFOR) United States $0.153B 0.00
Five Prime Therapeutics (FPRX) United States $0.150B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.148B 0.00
Alcobra (ARCT) United States $0.146B 0.00
Northwest Biotherapeutics (NWBO) United States $0.134B 0.00
Acorda Therapeutics (ACOR) United States $0.124B 0.00
SESEN BIO, INC (SESN) United States $0.121B 0.00
NantKwest (NK) United States $0.119B 0.00
Emmaus Life Sciences (EMMA) United States $0.118B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.117B 0.00
PHASEBIO PHARMA (PHAS) United States $0.116B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.113B 0.00
Abeona Therapeutics (ABEO) United States $0.111B 0.00
Novavax (NVAX) United States $0.111B 0.00
Menlo Therapeutics (MNLO) United States $0.110B 0.00
Aptinyx (APTX) United States $0.109B 0.00
Strongbridge Biopharma (SBBP) United States $0.109B 4.47
Adaptimmune Therapeutics (ADAP) United Kingdom $0.105B 0.00
Windtree Therapeutics (WINT) United States $0.103B 0.00
OvaScience (MLND) United States $0.097B 0.00
Celyad SA (CYAD) Belgium $0.097B 0.00
VBI Vaccines (VBIV) United States $0.096B 0.00
Fortress Biotech (FBIO) United States $0.090B 0.00
Trevena (TRVN) United States $0.089B 0.00
Liquidia Technologies (LQDA) United States $0.089B 0.00
Antibe Therapeutics (ATBPF) Canada $0.087B 0.00
Aduro Biotech (ADRO) United States $0.087B 0.00
Adocia (ADOCY) France $0.086B 0.00
Verastem (VSTM) United States $0.084B 0.00
Vaccinex (VCNX) United States $0.083B 0.00
Mersana Therapeutics (MRSN) United States $0.079B 0.00
Idera Pharmaceuticals (IDRA) United States $0.078B 0.00
Checkpoint Therapeutics (CKPT) United States $0.078B 0.00
VTv Therapeutics (VTVT) United States $0.077B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.077B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.074B 0.00
ARAVIVE, INC (ARAV) United States $0.073B 0.00
Prima BioMed (IMMP) Australia $0.072B 0.00
Curis (CRIS) United States $0.071B 0.00
Synlogic (SYBX) United States $0.070B 0.00
Catalyst Biosciences (CBIO) United States $0.067B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.065B 0.00
Selecta Biosciences (SELB) United States $0.063B 0.00
Orgenesis (ORGS) United States $0.060B 21.82
AquaBounty Technologies (AQB) United States $0.057B 0.00
Pluristem Therapeutics (PSTI) Israel $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.057B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.056B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.054B 0.00
Arbutus Biopharma (ABUS) Canada $0.053B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.051B 0.00
Unum Therapeutics (UMRX) United States $0.051B 0.00
VistaGen Therapeutics (VTGN) United States $0.050B 0.00
AIT Therapeutics (XAIR) United States $0.048B 0.00
NewLink Genetics (NLNK) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.047B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Evogene (EVGN) Israel $0.042B 0.00
Ophthotech (ISEE) United States $0.041B 0.00
Stellar Biotechnologies (EDSA) Canada $0.038B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.037B 0.00
Proteostasis Therapeutics (PTI) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
Oncobiologics (OTLK) United States $0.037B 0.00
Celsion (CLSN) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Clearside Biomedical (CLSD) United States $0.031B 0.00
Aptevo Therapeutics (APVO) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.87
BioCardia (BCDA) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.027B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
Apricus Biosciences (SEEL) United States $0.021B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Soligenix (SNGX) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.017B 0.00
Bionano Genomics (BNGO) United States $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
Pulmatrix (PULM) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Cleveland BioLabs (CBLI) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
TrovaGene (TROV) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Advaxis (ADXS) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Neuralstem (CUR) United States $0.003B 0.00